Response to Letter to the Editor on comments on Use of metformin and risk of kidney cancer in patients with type 2 diabetes Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52, pp. 19-25

Affiliations

¹ Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Division of Environmental Health and Occupational Medicine of the National Health Research Institutes, Zhunan, Taiwan. Electronic address: ccktsh@ms6.hinet.net.

Comment

Chin-Hsiao Tseng. Eur J Cancer. 2016 Jul.

. 2016 Jul:61:159-60.

doi: 10.1016/j.ejca.2016.03.064. Epub 2016 Apr 25.

¹ Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan; Division of Endocrinology and Metabolism, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Division of Environmental Health and Occupational Medicine of the National Health Research Institutes, Zhunan, Taiwan. Electronic address: ccktsh@ms6.hinet.net.

No abstract available

Comment on

Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
Tseng CH. Tseng CH. Eur J Cancer. 2016 Jan;52:19-25. doi: 10.1016/j.ejca.2015.09.027. Epub 2015 Nov 26. Eur J Cancer. 2016. PMID: 26630530
Comments on "Use of metformin and risk of kidney cancer in patients with type 2 diabetes", Chin-Hsiao Tseng, Eur J Cancer, 2016, No. 52, pp. 19-25.
de Jong RG, Nielen JT, Masclee AA, Janssen-Heijnen ML, de Vries F. de Jong RG, et al. Eur J Cancer. 2016 Jul;61:157-8. doi: 10.1016/j.ejca.2016.03.065. Epub 2016 Apr 27. Eur J Cancer. 2016. PMID: 27131610 No abstract available.